LLY

Eli Lilly & Co.
Data: 2026-08-21
$1255.4
Price
0.88%
Change
$1292.65
52W High
$694.23
52W Low

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Quick Stats
Aug 21, 2026

36.5

AI Score

SELL

0.96

Volume Ratio

TBA

Next Earnings

16

+ve Days (30d)

14

-ve Days (30d)

LLY Stock Summary

Last updated Aug 21, 2026

LLY is currently trading at $1255.4, positioned above its 200-day moving average of $1053.07, indicating a long-term uptrend. The stock has a 52-week range of $694.23 to $1292.65.

Technical Analysis: The 50-day moving average stands at $1179.58, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 59.493, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.036, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates LLY at 36.5/100 with a SELL recommendation.

LLY (Eli Lilly & Co.) Indicators

Last updated Aug 21, 2026

Indicator Value
RSI(14) 59.493
CMF (20) -0.036
ROC (10) 5.877
ADX (14) 22.327
Indicator Value
MACD (12,26,9) 20.674
AROONOSC (14) 85.714
WILLAMS %R (14) -20.301
MFI (14) 57.585
LLY Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

LLY Price vs Max Options Open Interest
LLY Max Change In Options Open Interest

LLY Options - Sort by Max open Interest (near term)

22nd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

LLY Daily Out of Money Options - Sort by Max open Interest (near term)

22nd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

LLY Daily In the Money Options - Sort by Max open Interest (near term)

22nd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

LLY Most Active Options by Volume(near term)

22nd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Eli Lilly & Co. is above both the 50 Day and 200 Day SMA which is considered Bullish.

LLY Moving Averages Analysis

Eli Lilly & Co. has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Aug 21, 2026

Eli Lilly & Co. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Aug 21, 2026

LLY (Eli Lilly & Co.) Simple Moving Averages

Moving Averages are last updated Aug 21, 2026

Days MA
10 1224.54
20 1198.1
30 1188.95
50 1179.58
100 1083.99
200 1053.07

LLY Fundamental Analysis

P/E (Forward) 35.2113
P/E (Trailing) 42.9251
Market Cap ($) 1.1 trillion
Earnings/Share ($) 28.99
Net Profit Margin (%) 0.3353
Dividend/Share ($) 6.46
EPS Estimate Current Year ($) 36.7251
EPS Estimate Next Year ($) 47.3303
WallStreet Target Price ($) 1310.90
Most Recent Quarter